Related Experiment Video

Updated: May 17, 2026

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

Molecular and cellular mechanisms of thymosin β4-mediated cardioprotection

Rabea Hinkel1, Teresa Trenkwalder, Christian Kupatt

  • 1Medizinische Klinik und Poliklinik I, Klinikum Großhadern, Ludwig Maximilians University, Munich, Germany. rabea.hinkel@med.uni-muenchen.de

Annals of the New York Academy of Sciences
|October 11, 2012
PubMed

Insights

Thymosin beta4 peptide shows promise for treating ischemic heart disease by promoting blood vessel growth and reducing inflammation. This peptide enhances cardiac survival and myocardial function after heart attacks.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Coronary heart disease remains a leading cause of mortality in industrialized nations.
  • Improving myocardial function and perfusion after myocardial infarction is critical for cardiac survival.
  • Thymosin beta4 is a peptide with pleiotropic abilities, showing potential for treating ischemic heart disease.

Purpose of the Study:

  • To investigate the therapeutic potential of Thymosin beta4 (Tβ4) in ischemic heart disease.
  • To elucidate the mechanisms underlying Tβ4's protective effects on the myocardium.
  • To evaluate Tβ4's role in vascularization and anti-inflammatory processes relevant to cardiac health.

Main Methods:

  • Review of existing literature on Thymosin beta4's function in cardiac development and adult physiology.
  • Analysis of Tβ4's impact on vasculogenesis, angiogenesis, and arteriogenesis.
  • Examination of Tβ4's effects on inflammatory pathways (NF-κB) and cell survival.

Main Results:

  • Tβ4 is essential for myocardial vascularization during development.
  • Tβ4 induces angiogenesis in adults through kinase activation.
  • Tβ4 exhibits anti-inflammatory properties by inhibiting NF-κB p65 activation.
  • Tβ4 promotes myocyte and endothelial cell survival and epicardial progenitor cell differentiation.

Conclusions:

  • Thymosin beta4 demonstrates significant potential as a therapeutic agent for ischemic heart disease.
  • Tβ4's multifaceted actions, including promoting vascularization and reducing inflammation, enhance cardiac survival.
  • Further research into Tβ4 could lead to novel treatments for heart conditions.

More Related Videos

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice06:42

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice

Published on: April 16, 2018

Isolation and Physiological Analysis of Mouse Cardiomyocytes11:02

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Published on: September 7, 2014

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...